Trial
NCT00859495
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Columbia University
Collaborators
—
Condition
Pleural Mesothelioma
Intervention
Doxorubicin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-25